Tempus AI, Inc. (TEM)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Genomics Revenue	955.38M	451.75M
Genomics Revenue Growth	111.48%	24.44%
Data and Services Revenue	316.41M	241.65M
Data and Services Revenue Growth	30.94%	43.16%
Revenue (Other)	1,000.00	-
Revenue (Total)	1.27B	693.40M
Revenue (Total) Growth	83.41%	30.38%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Remaining Total Contract Value (TCV)	1.10B	940.00M
Remaining Total Contract Value (TCV) Growth	17.02%	2.17%
Additional Potential Future Opt-Ins	300.00M	300.00M
Net Revenue Retention	126.00%	140.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai.